Journal Article
. 2015 May; 10(5):e0126219.
doi: 10.1371/journal.pone.0126219.

Post-operative plasma osteopontin predicts distant metastasis in human colorectal cancer

Lui Ng 1 Timothy Ming-Hun Wan 1 Colin Siu-Chi Lam 1 Ariel Ka-Man Chow 2 Sunny Kit-Man Wong 1 Johnny Hon-Wai Man 1 Hung-Sing Li 1 Nathan Shiu-Man Cheng 1 Ryan Chung-Hei Pak 1 Alvin Ho-Kwan Cheung 1 Thomas Chung-Cheung Yau 2 Oswens Siu-Hung Lo 1 Dominic Chi-Chung Foo 1 Jensen Tung-Chung Poon 1 Ronnie Tung-Ping Poon 2 Roberta Wen-Chi Pang 2 Wai-Lun Law 1 
Affiliations
  • PMID: 25961724
  •     42 References
  •     19 citations

Abstract

Background: The overall prognosis of colorectal cancer (CRC) patients is unsatisfactory due to cancer metastasis after operation. This study aims to investigate the clinical significance of plasma osteopontin (OPN) levels as minimally invasive, predictive, and surrogate biomarkers for prognosis of CRC patients.

Methods: This randomized study design consists of pre-operative and post-operative plasma samples from a total of 79 patients. We determined plasma levels of OPN by ELISA and examined their correlation with the clinicopathological parameters of CRC patients. The effects of endogenous and exogenous OPN on CRC metastasis were investigated by examination of the effect on regulators of epithelial to messenchymal transition and migration assay.

Results: Our findings demonstrated for the first time the clinical correlation of plasma OPN with metastasis of CRC patients. High post-operative plasma OPN level (>153.02 ng/ml) associated with development of metastasis after curative resection (p<0.001). Moreover, post-operative plasma OPN level correlated with disease-free survival of CRC patients (p=0.009) and was an independent factor for predicting development of metastasis in CRC patients after curative resection (p=0.036). Our in vitro model showed that OPN ectopic expression induced DLD1 cell migration through Snail and Twist1 overexpression and E-cadherin repression, and secretory OPN level enhanced cell migration.

Conclusions: The results of the current study suggest that post-operative plasma OPN correlated with post-operative metastasis, suggesting that it is a potential non-invasive biomarker for the development of future metastasis in CRC patients. In addition, OPN was shown to be involved in the metastatic process and thus inhibition of OPN is a potential therapeutic approach to treat CRC patients.

Primary prevention of colorectal cancer. The WHO Collaborating Centre for the Prevention of Colorectal Cancer.
M Shike, S J Winawer, +3 authors, S V Swaroop.
Bull World Health Organ, 1990 Jan 01; 68(3). PMID: 2203551    Free PMC article.
Review.
Osteopontin: a versatile regulator of inflammation and biomineralization.
C M Giachelli, S Steitz.
Matrix Biol, 2000 Dec 05; 19(7). PMID: 11102750
Highly Cited. Review.
Blood markers for early detection of colorectal cancer: a systematic review.
Sabrina Hundt, Ulrike Haug, Hermann Brenner.
Cancer Epidemiol Biomarkers Prev, 2007 Oct 13; 16(10). PMID: 17932341
Systematic Review.
Activation of the osteopontin/matrix metalloproteinase-9 pathway correlates with prostate cancer progression.
Giancarlo Castellano, Grazia Malaponte, +7 authors, Massimo Libra.
Clin Cancer Res, 2008 Nov 18; 14(22). PMID: 19010864
Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily.
H Shiraga, W Min, +7 authors, E G Neilson.
Proc Natl Acad Sci U S A, 1992 Jan 01; 89(1). PMID: 1729712    Free PMC article.
Highly Cited.
The regulation and role of osteopontin in malignant transformation and cancer.
Mohamed K El-Tanani, Frederick Charles Campbell, +3 authors, Philip S Rudland.
Cytokine Growth Factor Rev, 2006 Nov 23; 17(6). PMID: 17113338
Review.
Epithelial to mesenchymal transition inducing transcription factors and metastatic cancer.
Mousumi Tania, Md Asaduzzaman Khan, Junjiang Fu.
Tumour Biol, 2014 Jun 02; 35(8). PMID: 24880591
Highly Cited. Review.
Osteopontin-enhanced hepatic metastasis of colorectal cancer cells.
Jianjin Huang, Chi Pan, +2 authors, Ling Ding.
PLoS One, 2012 Nov 01; 7(10). PMID: 23112867    Free PMC article.
Expression of osteopontin coregulators in primary colorectal cancer and associated liver metastases.
D J Mole, C O'Neill, +6 authors, F C Campbell.
Br J Cancer, 2011 Feb 24; 104(6). PMID: 21343932    Free PMC article.
Secreted phosphoproteins associated with neoplastic transformation: close homology with plasma proteins cleaved during blood coagulation.
D R Senger, C A Perruzzi, +2 authors, D G Tenen.
Cancer Res, 1988 Oct 15; 48(20). PMID: 3167835
Clinical significance of osteopontin in esophageal squamous cell carcinoma: comparison with common tumor markers.
Yutaka Shimada, Go Watanabe, +8 authors, Masayuki Imamura.
Oncology, 2005 Jul 15; 68(2-3). PMID: 16015046
Integrative marker analysis allows risk assessment for metastasis in stage II colon cancer.
Ulrich Nitsche, Robert Rosenberg, +8 authors, Klaus-Peter Janssen.
Ann Surg, 2012 Oct 26; 256(5). PMID: 23095620
Elevated expression of secreted phosphoprotein I (osteopontin, 2ar) as a consequence of neoplastic transformation.
D R Senger, C A Perruzzi, A Papadopoulos.
Anticancer Res, 1989 Sep 01; 9(5). PMID: 2686530
Review.
The Role of Snail in EMT and Tumorigenesis.
Yifan Wang, Jian Shi, +2 authors, Binhua P Zhou.
Curr Cancer Drug Targets, 2013 Oct 31; 13(9). PMID: 24168186    Free PMC article.
Highly Cited. Review.
A humanized anti-osteopontin antibody inhibits breast cancer growth and metastasis in vivo.
Jianxin Dai, Bohua Li, +10 authors, Yajun Guo.
Cancer Immunol Immunother, 2009 Aug 20; 59(3). PMID: 19690854
Identification of colorectal cancer metastasis markers by an angiogenesis-related cytokine-antibody array.
Ana Abajo, Nerea Bitarte, +6 authors, Jesus Garcia-Foncillas.
World J Gastroenterol, 2012 Mar 01; 18(7). PMID: 22363134    Free PMC article.
Osteopontin regulates multiple functions contributing to human colon cancer development and progression.
R B Irby, S M McCarthy, T J Yeatman.
Clin Exp Metastasis, 2005 Feb 01; 21(6). PMID: 15679049
Clinical significance of the upregulated osteopontin mRNA expression in human colorectal cancer.
Wang Likui, Wang Hong, Zhang Shuwen.
J Gastrointest Surg, 2009 Sep 19; 14(1). PMID: 19763701
Osteopontin is overexpressed in colorectal carcinoma and is correlated with P53 by immunohistochemistry.
Jing Li, Guang-Zhi Yang, +2 authors, Lin Li.
Exp Ther Med, 2012 Sep 13; 3(4). PMID: 22969940    Free PMC article.
Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival.
H Singhal, D S Bautista, +4 authors, J F Harris.
Clin Cancer Res, 1997 Apr 01; 3(4). PMID: 9815727
Lower osteopontin plasma levels are associated with superior outcomes in advanced non-small-cell lung cancer patients receiving platinum-based chemotherapy: SWOG Study S0003.
Philip C Mack, Mary W Redman, +8 authors, SWOG.
J Clin Oncol, 2008 Sep 10; 26(29). PMID: 18779603    Free PMC article.
Epidermal growth factor receptor as a therapeutic target in colorectal cancer.
Roger B Cohen.
Clin Colorectal Cancer, 2003 Mar 07; 2(4). PMID: 12620146
Review.
Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin.
L W Fisher, D A Torchia, +2 authors, N S Fedarko.
Biochem Biophys Res Commun, 2001 Feb 13; 280(2). PMID: 11162539
Highly Cited.
The role of osteopontin in tumor progression and metastasis in breast cancer.
Lígia R Rodrigues, José A Teixeira, +2 authors, Helena Lindmark-Mänsson.
Cancer Epidemiol Biomarkers Prev, 2007 Jun 06; 16(6). PMID: 17548669
Review.
PDGFRB promotes liver metastasis formation of mesenchymal-like colorectal tumor cells.
Ernst J A Steller, Danielle A Raats, +9 authors, Onno Kranenburg.
Neoplasia, 2013 Feb 27; 15(2). PMID: 23441134    Free PMC article.
Genetic alterations in colorectal cancer.
Tannaz Armaghany, Jon D Wilson, Quyen Chu, Glenn Mills.
Gastrointest Cancer Res, 2012 May 11; 5(1). PMID: 22574233    Free PMC article.
Highly Cited.
Osteopontin is a marker for cancer aggressiveness and patient survival.
G F Weber, G S Lett, N C Haubein.
Br J Cancer, 2010 Sep 09; 103(6). PMID: 20823889    Free PMC article.
Biomarkers for predicting future metastasis of human gastrointestinal tumors.
Lui Ng, Ronnie Tung Ping Poon, Roberta Pang.
Cell Mol Life Sci, 2013 Feb 02; 70(19). PMID: 23370778
Review.
Loss of SMAD4 alters BMP signaling to promote colorectal cancer cell metastasis via activation of Rho and ROCK.
Philip W Voorneveld, Liudmila L Kodach, +15 authors, James C H Hardwick.
Gastroenterology, 2014 Apr 08; 147(1). PMID: 24704720
Plasma osteopontin: associations with survival and metastasis to bone in men with hormone-refractory prostate carcinoma.
Sebastien J Hotte, Eric W Winquist, +2 authors, Ann F Chambers.
Cancer, 2002 Sep 05; 95(3). PMID: 12209742
Twist: a molecular target in cancer therapeutics.
Md Asaduzzaman Khan, Han-chun Chen, Dianzheng Zhang, Junjiang Fu.
Tumour Biol, 2013 Jul 23; 34(5). PMID: 23873099
Highly Cited. Review.
The potential of osteopontin as a therapeutic target for human colorectal cancer.
Wang Likui, Wang Hong, +2 authors, Wen Yan.
J Gastrointest Surg, 2011 Feb 15; 15(4). PMID: 21318445
Elevated plasma osteopontin associated with gastric cancer development, invasion and survival.
Chun-Ying Wu, Ming-Shiang Wu, +6 authors, Jaw-Town Lin.
Gut, 2006 Dec 07; 56(6). PMID: 17148500    Free PMC article.
Alpha-catenin is required for IGF-I-induced cellular migration but not invasion in human colonic cancer cells.
Frédéric André, Barbara Janssens, +4 authors, Marc Bracke.
Oncogene, 2004 Feb 13; 23(6). PMID: 14961074
The role of CXCR3 and CXCR4 in colorectal cancer metastasis.
Teppei Murakami, Kenji Kawada, +8 authors, Yoshiharu Sakai.
Int J Cancer, 2012 Jun 13; 132(2). PMID: 22689289
Postoperative serum osteopontin level is a novel monitor for treatment response and tumor recurrence after resection of hepatitis B-related hepatocellular carcinoma.
Chuang Zhou, Hai-Jun Zhou, +12 authors, Lun-Xiu Qin.
Ann Surg Oncol, 2012 Dec 04; 20(3). PMID: 23203407
Reduction of elevated plasma osteopontin levels with resection of non-small-cell lung cancer.
Justin D Blasberg, Harvey I Pass, +3 authors, Jessica S Donington.
J Clin Oncol, 2010 Jan 21; 28(6). PMID: 20085934    Free PMC article.
Elevated plasma osteopontin as marker for distant metastases and poor survival in patients with renal cell carcinoma.
Azizbek Ramankulov, Michael Lein, +3 authors, Klaus Jung.
J Cancer Res Clin Oncol, 2007 May 05; 133(9). PMID: 17479289
Metastasis-inducing dna regulates the expression of the osteopontin gene by binding the transcription factor Tcf-4.
M El-Tanani, R Barraclough, M C Wilkinson, P S Rudland.
Cancer Res, 2001 Jul 17; 61(14). PMID: 11454716
Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation.
Alexandre Calon, Elisa Espinet, +14 authors, Eduard Batlle.
Cancer Cell, 2012 Nov 17; 22(5). PMID: 23153532    Free PMC article.
Highly Cited.
Soluble L1CAM promotes breast cancer cell adhesion and migration in vitro, but not invasion.
Yupei Li, Deni S Galileo.
Cancer Cell Int, 2010 Sep 16; 10. PMID: 20840789    Free PMC article.
Pre- and post-translational regulation of osteopontin in cancer.
Pieter H Anborgh, Jennifer C Mutrie, Alan B Tuck, Ann F Chambers.
J Cell Commun Signal, 2011 Apr 26; 5(2). PMID: 21516514    Free PMC article.
Osteopontin Overexpression Induced Tumor Progression and Chemoresistance to Oxaliplatin through Induction of Stem-Like Properties in Human Colorectal Cancer.
Lui Ng, Timothy Wan, +10 authors, Wai-Lun Law.
Stem Cells Int, 2015 Jun 25; 2015. PMID: 26106421    Free PMC article.
Comparison of (18)F-fluorodeoxyglucose PET/CT findings with vascular endothelial growth factors and receptors in colorectal cancer.
Ahmet Kocael, Betül Vatankulu, +6 authors, Kenan Ulualp.
Tumour Biol, 2015 Oct 20; 37(3). PMID: 26476536
Osteopontin-A Master Regulator of Epithelial-Mesenchymal Transition.
Anai N Kothari, Matthew L Arffa, +5 authors, Paul C Kuo.
J Clin Med, 2016 Mar 31; 5(4). PMID: 27023622    Free PMC article.
Review.
Immunomodulation Induced by Stem Cell Mobilization and Harvesting in Healthy Donors: Increased Systemic Osteopontin Levels after Treatment with Granulocyte Colony-Stimulating Factor.
Guro Kristin Melve, Elisabeth Ersvaer, +4 authors, Øystein Bruserud.
Int J Mol Sci, 2016 Jul 23; 17(7). PMID: 27447610    Free PMC article.
Analysis of different components in the peritumoral tissue microenvironment of colorectal cancer: A potential prospect in tumorigenesis.
Chao Huang, Hong Liu, +4 authors, Fengliang Hu.
Mol Med Rep, 2016 Aug 04; 14(3). PMID: 27484148    Free PMC article.
Osteopontin Fragments with Intact Thrombin-Sensitive Site Circulate in Cervical Cancer Patients.
Danny T M Leung, Pak-Leong Lim, +6 authors, Yick-Fu Wong.
PLoS One, 2016 Aug 06; 11(8). PMID: 27494141    Free PMC article.
The functional interplay between systemic cancer and the hematopoietic stem cell niche.
Amber J Giles, Christopher D Chien, +4 authors, Mark R Gilbert.
Pharmacol Ther, 2016 Sep 07; 168. PMID: 27595927    Free PMC article.
Review.
Human osteopontin: Potential clinical applications in cancer (Review).
Chengcheng Hao, Yuxin Cui, +3 authors, Wen G Jiang.
Int J Mol Med, 2017 Apr 26; 39(6). PMID: 28440483    Free PMC article.
Review.
Osteopontin -- a promising biomarker for cancer therapy.
Ran Wei, Janet Pik Ching Wong, Hang Fai Kwok.
J Cancer, 2017 Aug 19; 8(12). PMID: 28819419    Free PMC article.
Review.
The prognostic value of osteopontin in limited-stage small cell lung cancer patients and its mechanism.
Fanglei Liu, Chunxue Bai, Zhongliang Guo.
Oncotarget, 2017 Oct 21; 8(41). PMID: 29050263    Free PMC article.
The role of osteopontin in the progression of solid organ tumour.
Hailin Zhao, Qian Chen, +6 authors, Daqing Ma.
Cell Death Dis, 2018 Mar 04; 9(3). PMID: 29500465    Free PMC article.
Highly Cited. Review.
Suppression of Slit3 induces tumor proliferation and chemoresistance in hepatocellular carcinoma through activation of GSK3β/β-catenin pathway.
Lui Ng, Ariel K M Chow, +7 authors, Wai-Lun Law.
BMC Cancer, 2018 Jun 03; 18(1). PMID: 29859044    Free PMC article.
Enhanced osteopontin splicing regulated by RUNX2 is HDAC-dependent and induces invasive phenotypes in NSCLC cells.
Jing Huang, Siyuan Chang, +5 authors, Wen G Jiang.
Cancer Cell Int, 2019 Dec 14; 19. PMID: 31832019    Free PMC article.
Osteopontin as a Link between Inflammation and Cancer: The Thorax in the Spotlight.
Anne-Sophie Lamort, Ioanna Giopanou, Ioannis Psallidas, Georgios T Stathopoulos.
Cells, 2019 Aug 07; 8(8). PMID: 31382483    Free PMC article.
Review.
Epigenetic regulation of osteopontin splicing isoform c defines its role as a microenvironmental factor to promote the survival of colon cancer cells from 5-FU treatment.
Siyuan Chang, Jing Huang, +5 authors, Wei Ding.
Cancer Cell Int, 2020 Sep 19; 20. PMID: 32944000    Free PMC article.
Comprehensive Characterization of Stage IIIA Non-Small Cell Lung Carcinoma.
Neetu Singh, Archana Mishra, +8 authors, Shailendra Kumar.
Cancer Manag Res, 2020 Nov 28; 12. PMID: 33244273    Free PMC article.
Tumor-derived osteopontin drives the resident fibroblast to myofibroblast differentiation through Twist1 to promote breast cancer progression.
Ramesh Butti, Ramakrishna Nimma, +10 authors, Gopal C Kundu.
Oncogene, 2021 Feb 20; 40(11). PMID: 33603163
IS THERE A CLINICAL PATHOLOGICAL CORRELATION OF COLORECTAL ADENOCARCINOMA WITH THE IMMUNOHISTOCHEMICAL EXPRESSION OF OPN AND ABCB5?
Diogo Francesco Castoldi, Osvaldo Malafaia, +7 authors, Carmen Australia Paredes Marcondes Ribas.
Arq Bras Cir Dig, 2021 Mar 25; 33(4). PMID: 33759959    Free PMC article.
Evaluation of local and circulating osteopontin in malignant and benign primary bone tumors.
Ali Nazarizadeh, Shahin Alizadeh-Fanalou, +7 authors, Masoumeh Tavakoli-Yaraki.
J Bone Oncol, 2021 Jul 09; 29. PMID: 34235049    Free PMC article.